Results 51 to 60 of about 123 (78)

Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. [PDF]

open access: yesInt Immunopharmacol, 2020
Franzini M   +6 more
europepmc   +1 more source

Comparison of fully-vaccinated and non/partially-vaccinated critically-ill COVID-19 patients in terms of disease severity: a retrospective observational study. [PDF]

open access: yesBMC Infect Dis
Louis G   +11 more
europepmc   +1 more source

Resetting of the Human Circadian Melatonin Rhythm by Ambient Hypoxia. [PDF]

open access: yesJ Pineal Res
Post TE   +11 more
europepmc   +1 more source

ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically Ill COVID-19 Patients

open access: yes, 2021
Karakike E   +31 more
europepmc   +1 more source

Consistent multi-decadal variability in global temperature reconstructions and simulations over the Common Era. [PDF]

open access: yesNat Geosci, 2019
PAGES 2k Consortium   +19 more
europepmc   +1 more source

Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings

open access: yes, 2021
Chandna A   +38 more
europepmc   +1 more source

A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. [PDF]

open access: yesArch Dis Child Fetal Neonatal Ed, 2017
Sweet DG   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy